'We Want Them Infected'; Extra Vax Doses; Tom Cruise, Distancing Enforcer A daily roundup of news on COVID-19 and the rest of medicine Dec 17, 2020
FDA Panel Backs Entresto, Spironolactone for Broader HF Use But committee stops short of advocating categorical approval for HFpEF Dec 16, 2020
FDA OK's First-Ever Synthetic Implant for ACL Tears Bioresorbable device fills gap between torn ligament ends Dec 16, 2020
FDA Review Gives Rosy Outlook for What Could Be First HFpEF Drugs Advisory committee weigh unusual moves for Entresto and spironolactone Dec 14, 2020
Saxenda OK'd for Teens with Obesity Liraglutide label now includes adolescents as young as 12 Dec 07, 2020
FDA OKs 'Game Changer' Radiotracer for Prostate Cancer PET imaging drug detected metastasis at initial diagnosis, outperformed standard for PSA recurrence Dec 01, 2020
Colchicine Approval Took a Huge Toll on CMS As centuries-old drug is explored for COVID-19, study details the price of approval Nov 30, 2020
FDA OKs JAK Inhibitor and Remdesivir Combo for Severe COVID-19 EUA first for drug that acts on inflammation pathway, agency says Nov 19, 2020
Omega-3s Humbled by Corn Oil Placebo in Two Trials Implications for REDUCE-IT's icosapent ethyl unclear Nov 15, 2020
Omecamtiv's Benefit in HFrEF Trial Gets Lukewarm Reception Can novel oral drug stand out from the crowd? Nov 13, 2020
Doc Convicted for Needless Surgeries; COVID Test Racket; Biden's FDA Chief The past week in healthcare investigations Nov 11, 2020
Presbyopia Device Fails to Win Over FDA Panel Data suggest modest benefit and risk for scleral implant system Nov 10, 2020
Brilinta Wins Indication in Recurrent Stroke Prevention FDA approval based on THALES give the drug a foothold beyond CVD Nov 06, 2020
FDA Warns Against NSAIDs in Pregnancy After 20 Weeks Risk of kidney complications and low amniotic fluids may jeopardize fetus Oct 15, 2020
Reddit Users Self-Medicating With CBD for Treatable Conditions Patients may be substituting cannabis compound for evidence-based care Oct 15, 2020
FDA Panel: Some Risk OK for Olanzapine Combo With Less Weight Gain 11-6 majority said labeling was sufficient to mitigate dangers from opioid antagonist component Oct 09, 2020
FDA Panel: All Thumbs Down for Amphetamine Product Meant to Deter Abuse Unanimous vote that risks outweigh benefits Oct 09, 2020
Teen's Death Prompts Warning on 'Benadryl Challenge' FDA tries to squelch latest stupid craze Sep 25, 2020
How Accurate Are Home Blood Oxygen Monitors? The Skeptical Cardiologist examines pulse oximeters labeled not for medical use Sep 17, 2020
A Closer Look at FDA Decision to Pull Lorcaserin More cancers, multiple primaries, and deaths in CAMELLIA-TIMI 61 influenced agency decision Sep 09, 2020
Did Reformulated OxyContin Really Discourage Abuse? FDA advisors to review Purdue Pharma's flagship product, redesigned in 2010 to resist snorting and injection Sep 09, 2020
FDA Drops Boxed Warning From Invokana Label Amputation risk "lower than previously described" Aug 27, 2020
FDA OKs Anti-BCMA Drug for Multiple Myeloma Accelerated approval for belantamab mafodotin after four other therapies Aug 06, 2020
Triplet OK'd as First-Line Therapy in Melanoma Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
Essure Linked to Higher Rates of Abnormal Uterine Bleeding and Chronic Pain Early results of a post-market analysis show adverse effects after years of FDA action Jul 14, 2020
Heat-Not-Burn Cigarettes Win Coveted Marketing Claims FDA allows Marlboro Heatstick labels to boast "reduced exposure" though not "reduced risk" Jul 07, 2020
FDA Slaps Stem Cell Firm Linked to Nebraska Infections EUCYT Laboratories also pushing exosome treatments for COVID-19 Jun 23, 2020
HCQ No Longer Approved Even a Little for COVID-19 Study after study showed no benefit, and now the FDA has had enough Jun 15, 2020
New NMO Drug Gets FDA Nod B-cell depleting inebilizumab is the second neuromyelitis optica spectrum disorder treatment approved Jun 12, 2020
Telemedicine Abortion Gains Momentum During Pandemic But FDA regulations on mifepristone still limit access Jun 02, 2020
NDMA Prompts Metformin Recall FDA finds certain products with excessive levels of potential carcinogen May 29, 2020
Alzheimer’s Tau Tracer Wins Landmark Approval "Major advance" toward diagnosing Alzheimer's with brain imaging May 29, 2020
End of Life and COVID-19; DCIS Doubles Cancer Risk; Training for 'Bad News' News, features, and commentary about cancer-related issues May 28, 2020
Push Needed for At-Home Coronavirus Antibody Testing An opportunity for the U.S. to catch up Apr 15, 2020
Chloroquine Is Not a Harmless Panacea for COVID-19 There's a real safety concern with malaria drug Mar 23, 2020
Montelukast Warning Upgraded Existing risk information not prominent enough and needs a black box, FDA decides Mar 04, 2020
Spravato Debate Still Rages Journal airs questions about efficacy data, potential for harm Feb 20, 2020